Readystate Asset Management’s Aktis Oncology AKTS Stock Holding History
Bought
Maintained
Sold
Other funds holding AKTS
Readystate Asset Management's AKTS Position: Q3 2026 in Review
Readystate Asset Management sold out of Aktis Oncology (AKTS) in Q3 2026, closing a stake of 30,000 shares — an estimated $967K sold.
Readystate Asset Management first reported a position in AKTS in Q1 2026 and held it in 2 quarters. The position peaked at $967K in Q2 2026. 118 funds tracked by Wall St. Rank hold AKTS as of Q3 2026.
- Readystate Asset Management reported no remaining Aktis Oncology position as of Q3 2026 after selling out during the quarter.
- Readystate Asset Management sold 30,000 Aktis Oncology shares in Q3 2026, an estimated $967K.
- Readystate Asset Management first reported a position in Aktis Oncology in Q1 2026 and held it in 2 quarters.
- Readystate Asset Management's Aktis Oncology position peaked at $967K in Q2 2026.
- 118 funds tracked by Wall St. Rank held Aktis Oncology as of Q3 2026.
Based on Readystate Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.